Cargando…

TAVR and stroke: A common evolution

Periprocedural cerebrovascular events (CVE) after transcatheter aortic‐valve replacement (TAVR) are infrequent (but not rare) and fearsome complications. Stroke rates after TAVR remain below 4% in recent literature, but data on predictors of peri‐procedural CVE occurrence is generally controversial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarantini, Giuseppe, Cardaioli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544584/ https://www.ncbi.nlm.nih.gov/pubmed/35485733 http://dx.doi.org/10.1002/ccd.30220

Ejemplares similares

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Single center TAVR experience with a focus on the prevention and management of catastrophic complications
por: Kapadia, Samir R, et al.
Publicado: (2014)

Coronary access after ACURATE neo2 implantation for valve‐in‐valve TAVR: Insights from ex vivo simulations
por: Khokhar, Arif A., et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study
por: Pivato, Carlo A., et al.
Publicado: (2022)

Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction
por: Casenghi, Matteo, et al.
Publicado: (2021)

Long term follow‐up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications
por: Maurina, Matteo, et al.
Publicado: (2022)

A patient‐specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique
por: De Marco, Federico, et al.
Publicado: (2021)

Percutaneous approach to left ventricular assist device decommissioning
por: Moroni, Francesco, et al.
Publicado: (2022)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
por: Nara, Yugo, et al.
Publicado: (2019)

Conduction disorders using the Evolut R prosthesis compared with the CoreValve: has anything changed?
por: Perrin, Nils, et al.
Publicado: (2018)

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program
por: Hokken, Thijmen W., et al.
Publicado: (2021)

Percutaneous decannulation of extracorporeal membrane oxygenation using a plug‐based closure device
por: Dalén, Magnus, et al.
Publicado: (2022)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
por: Van Mieghem, Nicolas M., et al.
Publicado: (2021)

Percutaneous closure of patent foramen ovale for treatment of hypoxemia: A case series and physiology review
por: Robl, Jared, et al.
Publicado: (2022)

Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
por: Kooistra, Nynke H., et al.
Publicado: (2020)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Comparative differences of mitral valve‐in‐valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves
por: Wang, Dee Dee, et al.
Publicado: (2021)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs
por: van Wiechen, Maarten P., et al.
Publicado: (2021)

Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI‐NHR risk model
por: Al‐Farra, Hatem, et al.
Publicado: (2022)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

Doing procedures for patients rather than to patients
por: Malik, Shahbaz A., et al.
Publicado: (2022)

Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI
por: Venturi, Gabriele, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Mass to voltage ratio index predicts mortality following TAVI
por: Porat, Alon, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices
por: Korsholm, Kasper, et al.
Publicado: (2022)

Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement
por: Berkovitch, Anat, et al.
Publicado: (2022)

Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
por: Fanta, Lauren E., et al.
Publicado: (2022)

Facilitation techniques to cross the interatrial septum with intracardiac echocardiography during left atrial appendage closure
por: Vanhaverbeke, Maarten, et al.
Publicado: (2022)

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database
por: Ullah, Waqas, et al.
Publicado: (2022)

Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
por: Miller, Matthew S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcls2e56pptq68lb0ueife6d07